A Challenging Case of Corpus Callosum Anaplastic Astrocytoma

Ahmed K A Ahmed¹, Ahamed Elkhair^2, , Omeralfaroug Adam³, Mohamedanwar Ghandour⁴ and Rabab Elhassan¹

¹Countess of Chester Hospital, Chester, United Kingdom

²Faculty of Medicine, University of Medical Sciences and Technology, Khartoum, Sudan

³Department of Internal Medicine, Wayne State University/Detroit Medical Center, Michigan, USA

⁴Department of Internal Medicine, Nephrology division, Wayne State University/Detroit medical Center, Michigan, USA

Cite this paper:
Ahmed K A Ahmed, Ahamed Elkhair, Omeralfaroug Adam, Mohamedanwar Ghandour and Rabab Elhassan. A Challenging Case of Corpus Callosum Anaplastic Astrocytoma. American Journal of Medical Case Reports. 2021; 9(4):216-218. doi: 10.12691/ajmcr-9-4-3

Abstract

Anaplastic astrocytoma is a rare, malignant brain tumor that arises from astrocytes, with a poor prognosis. Herein, we report a challenging diagnostic case of a 76 years old female with an Anaplastic astrocytoma metastasized to the corpus callosum.

Keywords:
Anaplastic astrocytoma corpus callosum imaging CT MRI

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Louis DN, Ohgaki H, Wiestler OD et al. (2007). The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 114: 97-109.
[2]	Prados MD, Gutin PH, Phillips TL et al. (1992). Highly anaplastic astrocytoma: a review of 357 patients treated between 1977 and 1989. Int J Radiat Oncol Biol Phys 23: 3-8.
[3]	Mechtler L. Neuroimaging in neurooncology. Neurol. Clin. 27(1), 171-201, ix (2009).
[4]	Jansen NL, Graute V, Armbruster L et al. MRI-suspected low-grade glioma: is there a need to perform dynamic FET PET? Eur. J. Nucl. Med. Mol. Imaging 39(6), 1021-1029 (2012).
[5]	Ostrom QT, Gittleman H, Liao P, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. Neuro Oncol.2014; 4(16 Suppl.): iv1-iv63.
[6]	Pace A, Bove L, Innocenti P, et al. Epilepsy and gliomas: incidence and treatment in 119 patients. J. Exp. Clin. Cancer Res.1998; 17(4): 479-482.
[7]	Grimm SA, Chamberlain MC. Anaplasticastrocytoma. CNS Oncol. 2016; 5(3): 145-157.
[8]	K J Steltzer , , , , . Corpus callosum involvement as a prognostic factor for patients with high-grade astrocytoma. 1997 Apr 1; 38(1): 27-30.
[9]	Chaichana KL, et al. The butterfly effect on glioblastoma: Is volumetric extent of resection more effective than biopsy for these tumors? J. Neurooncol. 2014; 120: 625-634.
[10]	Dayani F, et al. Safety and outcomes of resection of butterfly glioblastoma. Neurosurg. Focus. 2018; 44: E4.
[11]	Chen KT, et al. Corpus callosum involvement and postoperative outcomes of patients with gliomas. J. Neurooncol. 2015; 124: 207-214.
[12]	Dziurzynski K, et al. Butterfly glioblastomas: A retrospective review and qualitative assessment of outcomes. J. Neurooncol. 2012; 109: 555-563.
[13]	Cairncross G, Wang M, Shaw E, et al. Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402. J. Clin. Oncol. 2013; 31(3): 337-343.